BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//UM//UM*Events//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/Detroit
TZURL:http://tzurl.org/zoneinfo/America/Detroit
X-LIC-LOCATION:America/Detroit
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20070311T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20071104T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20261111T081257
DTSTART;TZID=America/Detroit:20261203T150000
DTEND;TZID=America/Detroit:20261203T160000
SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series
DESCRIPTION:At the Cell–Matrix Interface: Inflammatory Signaling and the Mechanobiology of Tendinopathy \nAbstract:\nTendinopathy is a common and often persistent musculoskeletal disorder characterized by extracellular-matrix disorganization\, altered tissue mechanics\, and chronic inflammatory signaling. Yet the mechanisms linking changes in the extracellular matrix to sustained cellular dysfunction remain incompletely understood. This seminar will examine how nuclear factor kappa B (NF-κB) signaling contributes to tendon degeneration and repair\, with emphasis on the reciprocal relationship between tendon cells and their extracellular matrix. Using biomechanical\, cellular\, and preclinical models\, our work shows that dysregulated NF-κB activity can drive chronic tendon pathology and impair healing\, while targeted modulation of this pathway may improve tendon-to-bone repair. I will also discuss emerging evidence that matrix composition and mechanics shape fibroblast inflammatory responses\, metabolism\, and mechanosensing. Together\, these studies position the cell–matrix interface as a critical regulator of tendinopathy and a promising target for therapeutic development..    \nBio:\nAdam C. Abraham\, PhD\, is an Assistant Professor of Orthopaedic Surgery at the University of Michigan. Trained in mechanical engineering\, biomedical engineering\, musculoskeletal biology\, and immunology\, Dr. Abraham studies how mechanical loading\, extracellular-matrix properties\, and inflammatory signaling interact to regulate connective-tissue health and disease. His laboratory focuses on tendon mechanobiology and pathophysiology\, particularly the role of cell–extracellular matrix interactions in controlling fibroblast behavior and chronic inflammation. Dr. Abraham’s research has helped establish NF-κB signaling as a mechanistic driver and potential therapeutic target in tendinopathy and tendon-to-bone healing. His current National Institutes of Health-funded work examines how the extracellular matrix regulates inflammatory signaling in tendon. By integrating multiscale biomechanics\, engineered tissue models\, and preclinical disease models\, his research seeks to identify mechanisms that can be translated into improved treatments for tendon injury and degeneration.
UID:154790-21918356@events.umich.edu
URL:https://events.umich.edu/event/154790
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Basic Science,Bicentennial,Biointerfaces,Biology,biomedical,biomedical engineering,Bioninterfaces,Biosciences,Biotechnology,bme,engineer,engineering,Medicine,Michigan Engineering,North Campus,Research,seminar
LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130
CONTACT:
END:VEVENT
END:VCALENDAR